These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. RNA m6A methylation promotes the formation of vasculogenic mimicry in hepatocellular carcinoma via Hippo pathway. Qiao K; Liu Y; Xu Z; Zhang H; Zhang H; Zhang C; Chang Z; Lu X; Li Z; Luo C; Liu Y; Yang C; Sun T Angiogenesis; 2021 Feb; 24(1):83-96. PubMed ID: 32920668 [TBL] [Abstract][Full Text] [Related]
4. Long Non-Coding RNA HOXA-AS2 Regulates Malignant Glioma Behaviors and Vasculogenic Mimicry Formation via the MiR-373/EGFR Axis. Gao Y; Yu H; Liu Y; Liu X; Zheng J; Ma J; Gong W; Chen J; Zhao L; Tian Y; Xue Y Cell Physiol Biochem; 2018; 45(1):131-147. PubMed ID: 29310118 [TBL] [Abstract][Full Text] [Related]
5. METTL3 (Methyltransferase Like 3)-Dependent N6-Methyladenosine Modification on Li Q; Yu L; Gao A; Ren R; Zhang J; Cao L; Wang X; Liu Y; Qi W; Cai L; Li W; Wang W; Guo X; Su G; Yu X; Zhang J; Xi B; Zhang Y; Zhang M; Zhang C Arterioscler Thromb Vasc Biol; 2023 May; 43(5):755-773. PubMed ID: 36951060 [TBL] [Abstract][Full Text] [Related]
6. m6A methylated EphA2 and VEGFA through IGF2BP2/3 regulation promotes vasculogenic mimicry in colorectal cancer via PI3K/AKT and ERK1/2 signaling. Liu X; He H; Zhang F; Hu X; Bi F; Li K; Yu H; Zhao Y; Teng X; Li J; Wang L; Zhang Y; Wu Q Cell Death Dis; 2022 May; 13(5):483. PubMed ID: 35595748 [TBL] [Abstract][Full Text] [Related]
7. METTL3/IGF2BP2 axis affects the progression of colorectal cancer by regulating m6A modification of STAG3. Yi J; Peng F; Zhao J; Gong X Sci Rep; 2023 Oct; 13(1):17292. PubMed ID: 37828232 [TBL] [Abstract][Full Text] [Related]
8. The m6A Methyltransferase METTL3-Mediated N6-Methyladenosine Modification of DEK mRNA to Promote Gastric Cancer Cell Growth and Metastasis. Zhang HM; Qi FF; Wang J; Duan YY; Zhao LL; Wang YD; Zhang TC; Liao XH Int J Mol Sci; 2022 Jun; 23(12):. PubMed ID: 35742899 [TBL] [Abstract][Full Text] [Related]
9. RNA N6-methyladenosine methyltransferase-like 3 promotes liver cancer progression through YTHDF2-dependent posttranscriptional silencing of SOCS2. Chen M; Wei L; Law CT; Tsang FH; Shen J; Cheng CL; Tsang LH; Ho DW; Chiu DK; Lee JM; Wong CC; Ng IO; Wong CM Hepatology; 2018 Jun; 67(6):2254-2270. PubMed ID: 29171881 [TBL] [Abstract][Full Text] [Related]
11. METTL3 regulates N6-methyladenosine modification of ANGPTL3 mRNA and potentiates malignant progression of stomach adenocarcinoma. Zhang Z; Fu J; Zhang Y; Qin X; Wang Y; Xing C BMC Gastroenterol; 2023 Jun; 23(1):217. PubMed ID: 37344779 [TBL] [Abstract][Full Text] [Related]
12. METTL3 facilitates tumor progression via an m Li T; Hu PS; Zuo Z; Lin JF; Li X; Wu QN; Chen ZH; Zeng ZL; Wang F; Zheng J; Chen D; Li B; Kang TB; Xie D; Lin D; Ju HQ; Xu RH Mol Cancer; 2019 Jun; 18(1):112. PubMed ID: 31230592 [TBL] [Abstract][Full Text] [Related]
13. METTL3-Mediated RNA m6A Modification Regulates the Angiogenic Behaviors of Retinal Endothelial Cells by Methylating MMP2 and TIE2. Lin Y; Luo G; Liu Q; Yang R; Sol Reinach P; Yan D Invest Ophthalmol Vis Sci; 2023 Oct; 64(13):18. PubMed ID: 37819742 [TBL] [Abstract][Full Text] [Related]
14. Methyltransferase-like 3 promotes cervical cancer metastasis by enhancing cathepsin L mRNA stability in an N6-methyladenosine-dependent manner. Liu P; Ju M; Zheng X; Jiang Y; Yu X; Pan B; Luo R; Jia W; Zheng M Cancer Sci; 2023 Mar; 114(3):837-854. PubMed ID: 36382580 [TBL] [Abstract][Full Text] [Related]
15. METTL3 m6A-dependently promotes miR-21-5p maturation to accelerate choriocarcinoma progression via the HIF1AN-induced inactivation of the HIF1A/VEGF pathway. Ye K; Li L; Wu B; Wang D Genes Genomics; 2022 Nov; 44(11):1311-1322. PubMed ID: 36074324 [TBL] [Abstract][Full Text] [Related]
16. Genetic and pharmacological inhibition of METTL3 alleviates renal fibrosis by reducing EVL m6A modification through an IGF2BP2-dependent mechanism. Ni WJ; Zhou H; Lu H; Ma NN; Hou BB; Li W; Kong FX; Yu JT; Hou R; Jin J; Wen JG; Zhang T; Meng XM Clin Transl Med; 2023 Aug; 13(8):e1359. PubMed ID: 37537731 [TBL] [Abstract][Full Text] [Related]
17. METTL3 inhibits hepatic insulin sensitivity via N6-methyladenosine modification of Fasn mRNA and promoting fatty acid metabolism. Xie W; Ma LL; Xu YQ; Wang BH; Li SM Biochem Biophys Res Commun; 2019 Oct; 518(1):120-126. PubMed ID: 31405565 [TBL] [Abstract][Full Text] [Related]
18. Dysregulated N6-methyladenosine methylation writer METTL3 contributes to the proliferation and migration of gastric cancer. Liu T; Yang S; Sui J; Xu SY; Cheng YP; Shen B; Zhang Y; Zhang XM; Yin LH; Pu YP; Liang GY J Cell Physiol; 2020 Jan; 235(1):548-562. PubMed ID: 31232471 [TBL] [Abstract][Full Text] [Related]
19. METTL3 promotes prostate cancer progression by regulating miR-182 maturation in m6A-dependent manner. Wang D; Wang X; Huang B; Zhao Y; Tu W; Jin X; Shao Y; Zhu Y; Lu G Andrologia; 2022 Aug; 54(7):1581-1591. PubMed ID: 35413135 [TBL] [Abstract][Full Text] [Related]
20. Methyltransferase 3, N6-adenosine-methyltransferase complex catalytic subunit-induced long intergenic non-protein coding RNA 1833 N6-methyladenosine methylation promotes the non-small cell lung cancer progression via regulating heterogeneous nuclear ribonucleoprotein A2/B1 expression. Li D; Fu Z; Dong C; Song Y Bioengineered; 2022 Apr; 13(4):10493-10503. PubMed ID: 35441574 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]